Chemomab Therapeutics Ltd.
CMMB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,750 | -$2,100 | -$3,306 | -$2,987 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $0 | $0 | $0 | $0 |
| Other Non-Cash | $1,750 | $2,100 | $3,306 | $2,987 |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $0 |
| Forex Effect | $1,527 | -$2,882 | $2,331 | -$529 |
| Net Chg. in Cash | $1,527 | -$2,882 | $2,331 | -$529 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,596 | $8,478 | $6,147 | $6,676 |
| End Cash | $7,123 | $5,596 | $8,478 | $6,147 |
| Free Cash Flow | $0 | $0 | $0 | $0 |